Avaliação oftalmológica e laboratorial de coelhos hígidos tratados com os colírios dorzolamida a 2% e latanoprost a 0,005%
| Ano de defesa: | 2007 |
|---|---|
| Autor(a) principal: | |
| Orientador(a): | |
| Banca de defesa: | |
| Tipo de documento: | Dissertação |
| Tipo de acesso: | Acesso aberto |
| Idioma: | por |
| Instituição de defesa: |
Universidade Federal de Minas Gerais
|
| Programa de Pós-Graduação: |
Não Informado pela instituição
|
| Departamento: |
Não Informado pela instituição
|
| País: |
Não Informado pela instituição
|
| Palavras-chave em Português: | |
| Link de acesso: | https://hdl.handle.net/1843/SSLA-87ZQH5 |
Resumo: | The glaucoma is a progressive optical neuropathy generally associated to the increase of the intraocular pressure (IOP). The dorzolamide at 2% and the latanoprost at 0,005% are topical antiglaucoma drugs that cause significant reduction of the IOP. We decided to evaluate the local and systemic adverse effects of the dorzolamide at 2% and of the latanoprost at 0,005% in rabbits treated during 120 days. Eighteen rabbits were utilized, which were distributed in three groups (n=6). GI (latanoprost at 0,005%, SID); GII (dorzolamide at 2%, TID) and GIII (ultra-pure water, TID). Ophthalmological evaluation was carried out through daily clinical examination, Schirmer tear test and fluorescein stain. Also, the central corneal thickness (CCT) was measured as well as histopathologic evaluation of the eye and of annexes structures. For systemic evaluation was carried out blood count, biochemical analyses. At the end of the 120 days, of treatmentwere verified alterations in the eyelids and conjunctive and presence of eye secretion in respectively, 13,75% and 9,1% of the eyes of GI, 60% and 16,32% of the eyes of GII and, 0,62% and 0,48% of the eyes of GIII. The CCT test showed significant statistical difference only in the GII, where the CCT index was bigger in the end of the experiment. When facing the results, one can conclude that the treatment with the latanoprost at 0,005% promoted clinical alterations limited to the eyelids and the conjunctive of rabbits. In the other hand the dorzolamide at 2%, produced more intense alterations in the conjunctives and eyelids, lead to statistical significant increase in the CCT after 120 days of treatment |
| id |
UFMG_968cecff8d20d4b4a3f398dfe4a7363d |
|---|---|
| oai_identifier_str |
oai:repositorio.ufmg.br:1843/SSLA-87ZQH5 |
| network_acronym_str |
UFMG |
| network_name_str |
Repositório Institucional da UFMG |
| repository_id_str |
|
| spelling |
2019-08-11T11:30:45Z2025-09-09T01:01:20Z2019-08-11T11:30:45Z2007-04-03https://hdl.handle.net/1843/SSLA-87ZQH5The glaucoma is a progressive optical neuropathy generally associated to the increase of the intraocular pressure (IOP). The dorzolamide at 2% and the latanoprost at 0,005% are topical antiglaucoma drugs that cause significant reduction of the IOP. We decided to evaluate the local and systemic adverse effects of the dorzolamide at 2% and of the latanoprost at 0,005% in rabbits treated during 120 days. Eighteen rabbits were utilized, which were distributed in three groups (n=6). GI (latanoprost at 0,005%, SID); GII (dorzolamide at 2%, TID) and GIII (ultra-pure water, TID). Ophthalmological evaluation was carried out through daily clinical examination, Schirmer tear test and fluorescein stain. Also, the central corneal thickness (CCT) was measured as well as histopathologic evaluation of the eye and of annexes structures. For systemic evaluation was carried out blood count, biochemical analyses. At the end of the 120 days, of treatmentwere verified alterations in the eyelids and conjunctive and presence of eye secretion in respectively, 13,75% and 9,1% of the eyes of GI, 60% and 16,32% of the eyes of GII and, 0,62% and 0,48% of the eyes of GIII. The CCT test showed significant statistical difference only in the GII, where the CCT index was bigger in the end of the experiment. When facing the results, one can conclude that the treatment with the latanoprost at 0,005% promoted clinical alterations limited to the eyelids and the conjunctive of rabbits. In the other hand the dorzolamide at 2%, produced more intense alterations in the conjunctives and eyelids, lead to statistical significant increase in the CCT after 120 days of treatmentUniversidade Federal de Minas GeraisEfeitos adversosantiglaucomatososGlaucomaVeterináriaCoelho Doenças TratamentoPressão intra-ocularOlhos Efeitos de drogasAvaliação oftalmológica e laboratorial de coelhos hígidos tratados com os colírios dorzolamida a 2% e latanoprost a 0,005%info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisElaine Baptista Barbosainfo:eu-repo/semantics/openAccessporreponame:Repositório Institucional da UFMGinstname:Universidade Federal de Minas Gerais (UFMG)instacron:UFMGMarilia Martins MeloMaria Isabel Maldonado Coelho GuedesSebastiao Cronemberger SobrinhoRoselene EccoO glaucoma é uma neuropatia óptica progressiva geralmente associada ao aumento da pressão intra-ocular (PIO). A dorzolamida a 2% e o latanoprost a 0,005% são antiglaucomatosos tópicos que causam significativa redução da PIO em várias espécies animais. Decidiu-se avaliar os efeitos adversos locais e sistêmicos da dorzolamida a 2% e do latanoprost a 0,005% em coelhos hígidos tratados por 120 dias. Foram utilizados 18 coelhos, distribuídos em três grupos (n=6). GI (latanoprost a 0,005%, SID); GII (dorzolamida a 2%, TID) e GIII (água ultra-pura, TID). Avaliação oftalmológica foi realizada através de exame clínico diário, teste de Schirmer e fluoresceína, espessura corneana central (ECC) e avaliação histopatológica do olho e estruturas anexas. Para avaliação sistêmica foi realizado hemograma, análises bioquímicas. Ao final dos 120 dias, foram verificadas alterações nas pálpebras e conjuntivas e presença de secreção ocular em respectivamente, 13,75% e 9,1% dos olhos do GI, 60% e 16,32% dos olhos do GII e, 0,62% e 0,48% dos olhos do GIII. Na ECC houve diferença estatística significativa apenas no GII, onde a ECC foi maior ao final do experimento. Histopatologicamente, a única alteração relevante foi à distensão dos ductos das glândulas tarsais observada em um olho (8,33%) do GII. Diante dos resultados, permitiu-se concluir que o tratamento com o latanoprost a 0,005% promoveu apenas alterações clínicas nas pálpebras e conjuntivas de coelhos hígidos e, que a dorzolamida a 2%, além de produzir alterações mais intensas nas conjuntivas e pálpebras, provocou aumento estatisticamente significativo da ECC após 120 dias de tratamentoUFMGORIGINALdissertacaofinal___barbosa__e.b..pdfapplication/pdf1277976https://repositorio.ufmg.br//bitstreams/c2366d9d-2ae7-4eba-811f-3efa430c7b6c/downloadcce4506a585ed09d76f939fc917d8b26MD51trueAnonymousREADTEXTdissertacaofinal___barbosa__e.b..pdf.txttext/plain148250https://repositorio.ufmg.br//bitstreams/c9508f6a-1c5d-41fd-b950-d38e3054c6e7/download1302fbaa203b835dcc1aadbc716f0f3eMD52falseAnonymousREAD1843/SSLA-87ZQH52025-09-08 22:01:20.808open.accessoai:repositorio.ufmg.br:1843/SSLA-87ZQH5https://repositorio.ufmg.br/Repositório InstitucionalPUBhttps://repositorio.ufmg.br/oairepositorio@ufmg.bropendoar:2025-09-09T01:01:20Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG)false |
| dc.title.none.fl_str_mv |
Avaliação oftalmológica e laboratorial de coelhos hígidos tratados com os colírios dorzolamida a 2% e latanoprost a 0,005% |
| title |
Avaliação oftalmológica e laboratorial de coelhos hígidos tratados com os colírios dorzolamida a 2% e latanoprost a 0,005% |
| spellingShingle |
Avaliação oftalmológica e laboratorial de coelhos hígidos tratados com os colírios dorzolamida a 2% e latanoprost a 0,005% Elaine Baptista Barbosa Glaucoma Veterinária Coelho Doenças Tratamento Pressão intra-ocular Olhos Efeitos de drogas Efeitos adversos antiglaucomatosos |
| title_short |
Avaliação oftalmológica e laboratorial de coelhos hígidos tratados com os colírios dorzolamida a 2% e latanoprost a 0,005% |
| title_full |
Avaliação oftalmológica e laboratorial de coelhos hígidos tratados com os colírios dorzolamida a 2% e latanoprost a 0,005% |
| title_fullStr |
Avaliação oftalmológica e laboratorial de coelhos hígidos tratados com os colírios dorzolamida a 2% e latanoprost a 0,005% |
| title_full_unstemmed |
Avaliação oftalmológica e laboratorial de coelhos hígidos tratados com os colírios dorzolamida a 2% e latanoprost a 0,005% |
| title_sort |
Avaliação oftalmológica e laboratorial de coelhos hígidos tratados com os colírios dorzolamida a 2% e latanoprost a 0,005% |
| author |
Elaine Baptista Barbosa |
| author_facet |
Elaine Baptista Barbosa |
| author_role |
author |
| dc.contributor.author.fl_str_mv |
Elaine Baptista Barbosa |
| dc.subject.por.fl_str_mv |
Glaucoma Veterinária Coelho Doenças Tratamento Pressão intra-ocular Olhos Efeitos de drogas |
| topic |
Glaucoma Veterinária Coelho Doenças Tratamento Pressão intra-ocular Olhos Efeitos de drogas Efeitos adversos antiglaucomatosos |
| dc.subject.other.none.fl_str_mv |
Efeitos adversos antiglaucomatosos |
| description |
The glaucoma is a progressive optical neuropathy generally associated to the increase of the intraocular pressure (IOP). The dorzolamide at 2% and the latanoprost at 0,005% are topical antiglaucoma drugs that cause significant reduction of the IOP. We decided to evaluate the local and systemic adverse effects of the dorzolamide at 2% and of the latanoprost at 0,005% in rabbits treated during 120 days. Eighteen rabbits were utilized, which were distributed in three groups (n=6). GI (latanoprost at 0,005%, SID); GII (dorzolamide at 2%, TID) and GIII (ultra-pure water, TID). Ophthalmological evaluation was carried out through daily clinical examination, Schirmer tear test and fluorescein stain. Also, the central corneal thickness (CCT) was measured as well as histopathologic evaluation of the eye and of annexes structures. For systemic evaluation was carried out blood count, biochemical analyses. At the end of the 120 days, of treatmentwere verified alterations in the eyelids and conjunctive and presence of eye secretion in respectively, 13,75% and 9,1% of the eyes of GI, 60% and 16,32% of the eyes of GII and, 0,62% and 0,48% of the eyes of GIII. The CCT test showed significant statistical difference only in the GII, where the CCT index was bigger in the end of the experiment. When facing the results, one can conclude that the treatment with the latanoprost at 0,005% promoted clinical alterations limited to the eyelids and the conjunctive of rabbits. In the other hand the dorzolamide at 2%, produced more intense alterations in the conjunctives and eyelids, lead to statistical significant increase in the CCT after 120 days of treatment |
| publishDate |
2007 |
| dc.date.issued.fl_str_mv |
2007-04-03 |
| dc.date.accessioned.fl_str_mv |
2019-08-11T11:30:45Z 2025-09-09T01:01:20Z |
| dc.date.available.fl_str_mv |
2019-08-11T11:30:45Z |
| dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
| dc.type.driver.fl_str_mv |
info:eu-repo/semantics/masterThesis |
| format |
masterThesis |
| status_str |
publishedVersion |
| dc.identifier.uri.fl_str_mv |
https://hdl.handle.net/1843/SSLA-87ZQH5 |
| url |
https://hdl.handle.net/1843/SSLA-87ZQH5 |
| dc.language.iso.fl_str_mv |
por |
| language |
por |
| dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
| eu_rights_str_mv |
openAccess |
| dc.publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
| publisher.none.fl_str_mv |
Universidade Federal de Minas Gerais |
| dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFMG instname:Universidade Federal de Minas Gerais (UFMG) instacron:UFMG |
| instname_str |
Universidade Federal de Minas Gerais (UFMG) |
| instacron_str |
UFMG |
| institution |
UFMG |
| reponame_str |
Repositório Institucional da UFMG |
| collection |
Repositório Institucional da UFMG |
| bitstream.url.fl_str_mv |
https://repositorio.ufmg.br//bitstreams/c2366d9d-2ae7-4eba-811f-3efa430c7b6c/download https://repositorio.ufmg.br//bitstreams/c9508f6a-1c5d-41fd-b950-d38e3054c6e7/download |
| bitstream.checksum.fl_str_mv |
cce4506a585ed09d76f939fc917d8b26 1302fbaa203b835dcc1aadbc716f0f3e |
| bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 |
| repository.name.fl_str_mv |
Repositório Institucional da UFMG - Universidade Federal de Minas Gerais (UFMG) |
| repository.mail.fl_str_mv |
repositorio@ufmg.br |
| _version_ |
1862106079054266368 |